BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15161668)

  • 21. Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein.
    Rozemuller H; Rombouts EJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Br J Haematol; 1997 Sep; 98(4):952-9. PubMed ID: 9326195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin.
    Liu S; Bugge TH; Leppla SH
    J Biol Chem; 2001 May; 276(21):17976-84. PubMed ID: 11278833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor receptor-targeted therapy of chemotherapy- and radiation-resistant human myeloid leukemias.
    Perentesis JP; Bendel AE; Shao Y; Warman B; Davies SM; Yang CH; Chandan-Langlie M; Waddick KG; Uckun FM
    Leuk Lymphoma; 1997 Apr; 25(3-4):247-56. PubMed ID: 9168435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.
    Rustamzadeh E; Li C; Doumbia S; Hall WA; Vallera DA
    J Neurooncol; 2003 Oct; 65(1):63-75. PubMed ID: 14649886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 mice.
    Hall PD; Kreitman RJ; Willingham MC; Frankel AE
    Toxicol Appl Pharmacol; 1998 May; 150(1):91-7. PubMed ID: 9630457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
    Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
    Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia.
    Hall PD; Virella G; Willoughby T; Atchley DH; Kreitman RJ; Frankel AE
    Clin Immunol; 2001 Aug; 100(2):191-7. PubMed ID: 11465948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells.
    Burbage C; Tagge EP; Harris B; Hall P; Fu T; Willingham MC; Frankel AE
    Leuk Res; 1997 Jul; 21(7):681-90. PubMed ID: 9301690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequences within domain II of the urokinase receptor critical for differential ligand recognition.
    Li Y; Lawrence DA; Zhang L
    J Biol Chem; 2003 Aug; 278(32):29925-32. PubMed ID: 12761227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor.
    Perentesis JP; Waddick KG; Bendel AE; Shao Y; Warman BE; Chandan-Langlie M; Uckun FM
    Clin Cancer Res; 1997 Mar; 3(3):347-55. PubMed ID: 9815691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
    Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
    Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.
    Jakupovic I; Grandage VL; Linch DC; Khwaja A
    Blood; 2004 Apr; 103(8):3230-2. PubMed ID: 15070708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.
    Liu S; Bugge TH; Frankel AE; Leppla SH
    Methods Mol Biol; 2009; 539():175-90. PubMed ID: 19377974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
    Frankel AE; Powell BL; Hall PD; Case LD; Kreitman RJ
    Clin Cancer Res; 2002 May; 8(5):1004-13. PubMed ID: 12006512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.
    Westcott MM; Abi-Habib RJ; Cohen KA; Willingham MC; Liu S; Bugge TH; Leppla SH; Frankel AE
    Mol Cancer Ther; 2004 Dec; 3(12):1681-9. PubMed ID: 15634662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.